Loading…

VentasVTRCompetitor analysis, valuation and peers

United States · USD·Real Estate›Real Estate Investment Trusts

REIT that owns senior housing, medical office, life-science and hospital real estate leased mostly to healthcare operators.

Momentum strong 61
Mkt cap
$47.9B
US dollars, full cap
Free float
99%
of shares outstanding
$/day
$329M
20-day average traded
P/B
2.97×
price to book
ROE
1.9%
delivered
Implied ROE
20.2%
what the price asks
Official | Implied
BBB+ / BBB+
agencies · bond market
Next earnings
103 days
17 Feb 2027
Close · USD$88.75
1D-0.3%
1W+4.7%
1M+8.6%
3M-3.5%
6M+2.3%
YTD+16.1%
1Y+20.6%
ATR %2.6%
Beta-0.18
52w lowhigh12.7% off high

What Ventas does

REIT that owns senior housing, medical office, life-science and hospital real estate leased mostly to healthcare operators.

Earns two ways: rent from operators that run triple-net properties and pay the costs, which is steady, and a share of operating profit from senior-housing communities it owns and hires managers to run, which swings with occupancy and wages but offers more upside. Medical offices and life-science buildings are leased to health systems and research tenants.

Products and services

  • Senior housing operating/triple-net properties
  • Medical office/outpatient buildings
  • Life science/research real estate
  • Hospital/inpatient rehab properties

Customers

  • Senior housing/healthcare operators (tenants)
  • Health systems
  • Life-science tenants

Where it sits in the supply chain

  • Real estate
  • Healthcare REIT
  • Senior housing, medical office, life…

What could go right

  • Aging population driving senior-housing demand
  • Senior housing occupancy recovery post-pandemic

What could go wrong

  • Operator financial distress/labor-cost inflation
  • Interest-rate sensitivity of REIT valuations

Moat: narrow (scale, installed base). Large, diversified healthcare-property portfolio and long operator relationships built over decades.

Headquarters: Chicago, Illinois, United States · Founded: 1998 · Employees: 542

Named competitors

Ventas at a glance

Size Ventas (VTR) is a United States Real Estate company (Real Estate Investment Trusts) with a market value of $47.9B, the 263rd largest of 3,117 United States companies the cockpit tracks. Shares closed at $88.75 on 6 Nov 2026.

Performance Over six months the shares gained 2.3%, against -1.2% for the median peer and -1.1% for the United States market (cap-weighted) — 9th highest of 20 in its peer set.

Growth Revenue grew 22.1% over the last twelve months (peer median +5.0%); the operating margin is 14.6% (peer median 36.6%).

Valuation It trades at 2.97× book value against a peer median of 2.39× (7th most expensive of 18).

Price implies The share price implies a return on equity of about 20.2%; Ventas delivers 1.9%, so the price asks more than the business earns today.

Credit Ventas has 12 bonds outstanding ($6.10B), rated BBB+ by the agencies and trading like BBB+ at a weighted spread of 84 bp.

Short interest Short interest is 2.8% of the free float (15 Oct 2026).

Next results Next results expected around 17 Feb 2027 (exchange calendar; dates can move).

Relative performance

9010011011 May 202611 Aug 20266 Nov 2026VTR 102Peer median 99
Six months, rebased to 100: Ventas against the median of its 20 peers (local-currency closes).

Ventas financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$6.78B$5.84B$4.95B$4.50B$4.13B
Revenue growth—+18%+10%+9%—
Gross profit$1.22B$1.10B$919M$771M$756M
EBITDA$2.46B$2.18B$1.87B$1.83B$1.62B
Net income$262M$251M$81.2M-$41.0M-$47.4M
Free cash flow$1.50B$1.32B$1.06B$935M$926M
Capital expenditure$457M$364M$282M$259M$222M
Total debt$12.7B$13.3B$13.8B$13.8B$12.6B

Quarterly statements and history in the cockpit →

Ventas competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-20%0%+20%0%+10%+20%+30%OGMGCCIPSADLREXRIRMSPGVICIAMTEQIXSBACPLDESSHSTSGROLAMRINVHVTR6-month return →1-month return →
Up and to the right = strong over both horizons. Ventas is the large dot.

Fundamentals: return on equity against price-to-book

0%50%100%00×100×200×VMRKOPSADLRSPGAMTEQIXLAMRVTRReturn on equity →Price / book →
A bank or insurer earning more on its equity usually trades at a higher multiple of book; points far above the trend are priced for more. Ventas is the large dot.

Capital: ROE delivered against the ROE the price implies

0%50%100%150%0%50%100%150%VMRKOGMGPSADLRSPGAMTLAMRVTRROE delivered →ROE the price implies →
Above the diagonal = the price asks for a higher return on equity than the business earns today. Ventas is the large dot.

Ventas competitors and peer comparison

Head to head with its named competitors (VTR vs WELL vs DOC vs OHI)
CompanyMarket cap6M returnRevenue growthROEPrice / bookImplied ROE
Ventas VTR$47.9B+2%+22%2%2.97×20.2%
Welltower WELL$180B+15%+39%4%3.69×24.4%
Healthpeak Properties DOC$14.3B+4%+9%5%1.78×15.1%
Omega Healthcare Investors OHI$14.6B+2%+14%14%2.66×15.3%

How Ventas compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Ventas against its 20 peers (data as of 6 Nov 2026)
MeasureVTRPeer medianRank in peer set
1-month return+8.6%+8.9%10th lowest of 21
6-month return+2.3%-1.2%9th highest of 20
Return on equity1.9%8.1%lowest of 18
Price / book2.97×2.39×7th most expensive of 18
Trailing P/E167.9×30.8×2nd most expensive of 21
ROE the price implies20.2%20.9%8th least demanding of 17
ROE delivered1.9%8.1%lowest of 18
Bond spread84 bp93 bp7th tightest of 20

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthROEPrice / bookImplied ROEDelivered ROE
Ventas VTRUnited States$47.9B+2%+22%2%2.97×20.2%1.9%
Equity Residential VMRKUnited States$50.7Bn/a+4%8%2.34×16.0%8.1%
Realty Income OUnited States$56.1B-4%+11%3%1.42×10.3%3.5%
Goodman GMG.AXAustralia$39.6B-11%+17%12%2.28×26.9%11.5%
Crown Castle CCIUnited States$37.7B-1%-16%n/an/an/an/a
Public Storage PSAUnited States$63.1B+10%+5%16%6.45×43.1%16.0%
Digital Realty DLRUnited States$65.9B-10%+21%4%2.39×19.2%3.6%
Extra Space Storage EXRUnited States$33.2B+12%+4%8%2.59×21.8%7.8%
Iron Mountain IRMUnited States$31.7B-17%+17%n/an/an/an/a
Simon Property SPGUnited States$73.9B+14%+15%135%16.82×143.3%135.4%
Vici Properties VICIUnited States$27.3B-13%+5%8%0.94×7.9%8.3%
American Tower AMTUnited States$87.6B+8%+5%89%24.92×155.2%88.7%
Equinix EQIXUnited States$100B-5%+11%26%7.03×n/a25.8%
SBA Communications SBACUnited States$19.8B-13%+2%n/an/an/an/a
Prologis PLDUnited States$123B-11%+7%8%2.16×20.9%7.9%
Essex Property Trust ESSUnited States$17.5B+4%+5%6%3.30×20.8%6.4%
Kimco Realty KIMUnited States$17.0B+10%+3%7%1.67×13.9%7.2%
Host Hotels & Resorts HSTUnited States$16.9B+15%+5%16%2.64×22.6%15.8%
SEGRO SGRO.LUnited Kingdom$16.6B+33%+7%2%1.03×14.8%2.5%
Lamar Advertising LAMRUnited States$15.8B-1%+4%59%16.13×134.1%58.9%
Invitation Homes INVHUnited States$15.6B-5%+5%7%1.79×13.6%7.4%

Ventas bonds and credit

Ventas has 12 bonds outstanding with $6.10B face value. The agencies rate it BBB+; its bonds trade like BBB+. Weighted yield 5.51%, a spread of 84 bp over government bonds.

Every bond, yield and spread in the cockpit →

Questions

Who are Ventas's main competitors?
Named competitors: Welltower (WELL), Healthpeak Properties (DOC), Omega Healthcare Investors (OHI). The cockpit's measured peer set (industry) also includes Equity Residential (VMRK), Realty Income (O), Goodman (GMG.AX), Crown Castle (CCI), Public Storage (PSA), Digital Realty (DLR).
Is Ventas expensive compared with its peers?
On price / book it trades at 2.97× against a peer median of 2.39×, 7th most expensive of 18 in its peer set. The share price implies a return on equity of about 20.2%; Ventas delivers 1.9%, so the price asks more than the business earns today.
How has Ventas stock performed?
Over six months to 6 Nov 2026 the shares returned +2.3% against -1.2% for the median peer; over one year +20.6%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.